Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...

Brensocatib is Currently Under Priority Review with the U.S. Food and Drug Administration— BRIDGEWATER, N.J., April 23, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM ...

Incorporated announced that positive results from the pivotal phase 3 ASPEN study of brensocatib in patients with non-cystic ...

How to Discuss Diversity in Medical School Essays? Writing personal statements and other essays for medical school can be daunting, as applicants have a limited number of words to discuss their ...